Transcranial Magnetic Stimulation (TMS) therapy is safe, side-effect free, and approved by the FDA. TMS has been the subject of numerous clinical studies and is currently being used at some of the most trusted and respected clinics, hospitals, and universities in North America.
TMS proves to be an effective therapy for major depression in this multisite observational report.
Open-label, evidence-based analysis finds TMS to be an effective and long-lasting depression treatment.
Study determines TMS therapy is effective, safe, and free of major side effects.
Top hospitals and universities using TMS therapy
TMS therapy: are you covered?
TMS in practice — a physician's perspective
Dr. Terry Hanusa, MD
Transcranial Magnetic Stimulation was approved by the FDA in 2008 and is now being used since used in doctors’ offices, world class hospitals, and leading universities. Today, the treatment is even covered by most insurance, including Medicare.
Cumulative benefits free of harmful side effects
Our office has been using TMS therapy since August 2010. We have treated more than 500 individual patients; which equals approximately 15,000 treatments. While the learning process is continuous, we’ve found one variable that remains constant—the total exposure of treatments is cumulative. In other words, the more treatments a patient has, the more robust the response. Along with that is the fact that this treatment is found to be more effective than any singular antidepressant. TMS is non-systemic, which means that the common side effects of anti-depressants are avoided, making it an ideal treatment for depression and anxiety. Patients no longer need to struggle with anti-depressant medication symptoms such as weight gain, dry mouth, sexual dysfunction, and gastrointestinal issues, leading to a much easier road to recovery.
A quick and stress-free inpatient experience
As for the treatment process, patients come in anywhere from three to five times a week for about four to six weeks. We typically recommend approximately 30 treatments in total. When they come in they can either come alone or with a relative. The patient sits in a relaxed position during the treatment, which lasts about 20 minutes. Afterward, patients are safe to drive themselves home and resume normal activities. We have a wide range of ages among our patients, all of which find the treatment very easy to tolerate and complete, with notice that younger patients tend to respond particularly well.
2 out of 3 patients experience remission
Overall, TMS therapy has shown an incredibly high degree of promise, especially when compared to other treatments. From a statistical viewpoint, we have a remission rate of two out of every three patients. The treatment itself is being studied and developed even further to see if there is a possibility in treating other diagnoses, and is already showing great success in off-label trials.